Search
Search
About
Log in
Join
Experiences with
Daclatasvir
Posts
Communities
23 public posts
Filter results
Hep c medicine
Has anyone took sofusbuvir and
daclatasvir
and did they get a good response for geno 3?
Has anyone took sofusbuvir and
daclatasvir
and did they get a good response for geno 3?
Surjy
in
Hepatitis C Trust
6 years ago
HCV patients with renal dysfunction safely achieve SVR with daclatasvir/asunaprevir
A successful regimen for HCV patients with all different levels of renal dysfunction has finally been found! Success rates were over 88% and discontinuation rates were also very low, under 12%. http://bit.ly/2jfhMhI
A successful regimen for HCV patients with all different levels of renal dysfunction has finally been found! Success rates were over 88% and discontinuation rates were also very low, under 12%. http://bit.ly/2jfhMhI
HFIAdmin
in
Hepatitis C Support
7 years ago
HCV patients with renal dysfunction safely achieve SVR with daclatasvir/asunaprevir
A successful regimen for HCV patients with all different levels of renal dysfunction has finally been found! Success rates were over 88% and discontinuation rates were also very low, under 12%. http://bit.ly/2jfhMhI
A successful regimen for HCV patients with all different levels of renal dysfunction has finally been found! Success rates were over 88% and discontinuation rates were also very low, under 12%. http://bit.ly/2jfhMhI
HFIAdmin
in
HFI Connect - Hepatitis
7 years ago
Want to take advantage of all our features? Just log in!
Log in
or
Join
Hepatitis News : BMS Offers Generic Daclatasvir for Hepatitis C in 112 Countries
http://www.hepmag.com/articles/bms_generic_daclatasvir_2831_28166.shtml?utm_source=phplist36&utm_medium=email&utm_content=HTML&utm_campaign=Success+in+Adding+Sovaldi+to+Hep+C+Re-Treatment
http://www.hepmag.com/articles/bms_generic_daclatasvir_2831_28166.shtml?utm_source=phplist36&utm_medium=email&utm_content=HTML&utm_campaign=Success+in+Adding+Sovaldi+to+Hep+C+Re-Treatment
kcohen
in
HFI Connect - Hepatitis
8 years ago
FDA OK’s BMS Daklinza (Daclatasvir) to Treat Hep C Genotype 3
To read more from the press release, click here : http://www.businesswire.com/news/home/20150724005696/en/FDA-Approves-Daklinza-
daclatasvir
-Treatment-Patients-Chronic#.VbZj6flVikp
To read more from the press release, click here : http://www.businesswire.com/news/home/20150724005696/en/FDA-Approves-Daklinza-
daclatasvir
-Treatment-Patients-Chronic#.VbZj6flVikp
kcohen
in
HFI Connect - Hepatitis
9 years ago
Harvoni and Sovaldi/Daclatasvir Safer to Mix With HIV Meds
Such DDIs would be expected with 70 percent of the HIV regimens if combined with Olysio/Sovaldi, 61 percent with Viekira Pak, 64 percent with Harvoni, and 47 percent with Sovaldi/
daclatasvir
.
Such DDIs would be expected with 70 percent of the HIV regimens if combined with Olysio/Sovaldi, 61 percent with Viekira Pak, 64 percent with Harvoni, and 47 percent with Sovaldi/
daclatasvir
.
kuzoigwe
in
HFI Connect - Hepatitis
9 years ago
8 Weeks of Daclatasvir/Sovaldi Cures Some With HCV/HIV
All the participants who took eight weeks of
daclatasvir
and Sovaldi were treatment naive.. Of those treated for 12 weeks, 101 were treatment naive and 52 were treatment experienced.
All the participants who took eight weeks of
daclatasvir
and Sovaldi were treatment naive.. Of those treated for 12 weeks, 101 were treatment naive and 52 were treatment experienced.
kuzoigwe
in
HFI Connect - Hepatitis
9 years ago
8 Weeks of Daclatasvir/Sovaldi Cures Some With HCV/HIV
All the participants who took eight weeks of
daclatasvir
and Sovaldi were treatment naive.. Of those treated for 12 weeks, 101 were treatment naive and 52 were treatment experienced.
All the participants who took eight weeks of
daclatasvir
and Sovaldi were treatment naive.. Of those treated for 12 weeks, 101 were treatment naive and 52 were treatment experienced.
kuzoigwe
in
HFI Connect - Hepatitis
9 years ago
Eyeing big returns, drugmakers ready new hepatitis-C drug launches
The FDA also last week approved Daklinza (
daclatasvir
), a treatment developed by Bristol-Myers Squibb to treat genotype-3 infections in combination with Sovaldi. It does not require the co-administration of interferon or ribavirin.
The FDA also last week approved Daklinza (
daclatasvir
), a treatment developed by Bristol-Myers Squibb to treat genotype-3 infections in combination with Sovaldi. It does not require the co-administration of interferon or ribavirin.
kcohen
in
HFI Connect - Hepatitis
9 years ago
World Health Organization Throws Weight Behind Hep C Treatments
Included in the list are Gilead Sciences’ Sovaldi (sofosbuvir) and Harvoni (ledipasvir/sofosbuvir), Janssen’s Olysio (simeprevir), Bristol-Myers Squibb’s
daclatasvir
, and the two components of AbbVie’s Viekira Pak (ombitasvir/paritaprevir/ritonavir; dasabuvir), as well as interferon and ribavirin.
Included in the list are Gilead Sciences’ Sovaldi (sofosbuvir) and Harvoni (ledipasvir/sofosbuvir), Janssen’s Olysio (simeprevir), Bristol-Myers Squibb’s
daclatasvir
, and the two components of AbbVie’s Viekira Pak (ombitasvir/paritaprevir/ritonavir; dasabuvir), as well as interferon and ribavirin.
kuzoigwe
in
HFI Connect - Hepatitis
9 years ago
World Health Organization Throws Weight Behind Hep C Treatments
Included in the list are Gilead Sciences’ Sovaldi (sofosbuvir) and Harvoni (ledipasvir/sofosbuvir), Janssen’s Olysio (simeprevir), Bristol-Myers Squibb’s
daclatasvir
, and the two components of AbbVie’s Viekira Pak (ombitasvir/paritaprevir/ritonavir; dasabuvir), as well as interferon and ribavirin.
Included in the list are Gilead Sciences’ Sovaldi (sofosbuvir) and Harvoni (ledipasvir/sofosbuvir), Janssen’s Olysio (simeprevir), Bristol-Myers Squibb’s
daclatasvir
, and the two components of AbbVie’s Viekira Pak (ombitasvir/paritaprevir/ritonavir; dasabuvir), as well as interferon and ribavirin.
kuzoigwe
in
HFI Connect - Hepatitis
9 years ago
WHO Adds New Hepatitis C Drugs to Essential Medicines List
Specifically, the WHO added sofosbuvir (brand name Sovaldi) to the guide, as well as simeprevir (Olysio),
daclatasvir
, ribavirin and the non-nucleoside polymerase inhibitor dasabuvir.
Specifically, the WHO added sofosbuvir (brand name Sovaldi) to the guide, as well as simeprevir (Olysio),
daclatasvir
, ribavirin and the non-nucleoside polymerase inhibitor dasabuvir.
kuzoigwe
in
HFI Connect - Hepatitis
9 years ago
Cure for Almost All Hep C-Positive Liver Transplantees
Bristol-Myers Squibb’s
daclatasvir
and Gilead Sciences’ Sovaldi (sofosbuvir), with or without ribavirin, offer near-perfect hepatitis C virus (HCV) cure rates among those who have received a liver transplant.
Bristol-Myers Squibb’s
daclatasvir
and Gilead Sciences’ Sovaldi (sofosbuvir), with or without ribavirin, offer near-perfect hepatitis C virus (HCV) cure rates among those who have received a liver transplant.
kuzoigwe
in
HFI Connect - Hepatitis
9 years ago
Daclatasvir Plus Sovaldi Shows Promise Curing Hard-to-Treat Hep C
Bristol-Myers Squibb’s
daclatasvir
and Gilead Sciences’ Sovaldi (sofosbuvir), with or without ribavirin, seem likely to lead to relatively good cure rates among people with genotype 3 of hepatitis C virus.
Bristol-Myers Squibb’s
daclatasvir
and Gilead Sciences’ Sovaldi (sofosbuvir), with or without ribavirin, seem likely to lead to relatively good cure rates among people with genotype 3 of hepatitis C virus.
kuzoigwe
in
HFI Connect - Hepatitis
9 years ago
Sofosbuvir/Daclatasvir Combination Effective in Hepatitis C Treatment - See more at: http://www.specialtypharmacytimes.com/news/Sofosbuvir-D
he combination of sofosbuvir and
daclatasvir
showed promising results for the treatment of hepatitis C virus (HCV) during a recent clinical trial, which was the first to evaluate this drug combination in a real world setting. - See more at: http://www.specialtypharmacytimes.com/news/Sofosbuvir-
Daclatasvir
-Combination-Effective-in-Hepatitis-C-Treatment
he combination of sofosbuvir and
daclatasvir
showed promising results for the treatment of hepatitis C virus (HCV) during a recent clinical trial, which was the first to evaluate this drug combination in a real world setting. - See more at: http://www.specialtypharmacytimes.com/news/Sofosbuvir-
Daclatasvir
-Combination-Effective-in-Hepatitis-C-Treatment
mwright
in
HFI Connect - Hepatitis
9 years ago
Daclatasvir and Sovaldi Cure High Rates of Genotype 1 of Hep C
A recent trial suggests that Bristol-Myers Squibb’s
daclatasvir
plus Gilead Sciences’ Sovaldi (sofosbuvir), with or without ribavirin, cures high rates of people with genotype 1 of hepatitis C virus (HCV), including those with cirrhosis.
A recent trial suggests that Bristol-Myers Squibb’s
daclatasvir
plus Gilead Sciences’ Sovaldi (sofosbuvir), with or without ribavirin, cures high rates of people with genotype 1 of hepatitis C virus (HCV), including those with cirrhosis.
kuzoigwe
in
HFI Connect - Hepatitis
9 years ago
ANRS CO23 CULPIT: Sovaldi, daclatasvir well tolerated in transplant, recurrence
http://fb.me/7iyXKbbYz
http://fb.me/7iyXKbbYz
kuzoigwe
in
HFI Connect - Hepatitis
9 years ago
High Hep C Cure Rate for Daclatasvir and Sovaldi in Those With HIV
http://www.hepmag.com/articles/daclatasvir_sofosbuvir_coinfection_2501_27116.shtml
http://www.hepmag.com/articles/daclatasvir_sofosbuvir_coinfection_2501_27116.shtml
kuzoigwe
in
HFI Connect - Hepatitis
9 years ago
High Hep C Cure Rate for Daclatasvir and Sovaldi in Those With HIV
http://www.poz.com/articles/daclatasvir_sofosbuvir_coinfection_761_27116.shtml
http://www.poz.com/articles/daclatasvir_sofosbuvir_coinfection_761_27116.shtml
kuzoigwe
in
HFI Connect - Hepatitis
9 years ago
ALLY-1 Trial Results
ALLY-1 Trial Results Show Investigational
Daclatasvir
-Based Regimen Cures 94% of Post-Liver Transplant Patients with Hepatitis C and Up to 94% of Hepatitis C Patients with Cirrhosis (Child-Pugh Class A or B) http://hepatitiscresearchandnewsupdates.blogspot.com/2015/04/ally-1-trial-results-show.html
ALLY-1 Trial Results Show Investigational
Daclatasvir
-Based Regimen Cures 94% of Post-Liver Transplant Patients with Hepatitis C and Up to 94% of Hepatitis C Patients with Cirrhosis (Child-Pugh Class A or B) http://hepatitiscresearchandnewsupdates.blogspot.com/2015/04/ally-1-trial-results-show.html
kuzoigwe
in
HFI Connect - Hepatitis
9 years ago
1
2
Next page
Filter results
Clear filters
Posted in
All communities
HFI Connect - Hepatitis
19 results
British Liver Trust
1 result
Cure Parkinson's
1 result
View top 10 communities
Sort by
Most Relevant
Newest